MENU
+Compare
SBFM
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$2.90
Change
+$0.07 (+2.47%)
Capitalization
6.02M

SBFM Sunshine Biopharma Inc Forecast, Technical & Fundamental Analysis

SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SBFM with price predictions
Jan 08, 2025

SBFM saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for SBFM moved out of overbought territory on January 06, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 28 similar instances where the indicator exited the overbought zone. In of the 28 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SBFM as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBFM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SBFM broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SBFM just turned positive on December 23, 2024. Looking at past instances where SBFM's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

SBFM moved above its 50-day moving average on December 23, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SBFM advanced for three days, in of 174 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.482) is normal, around the industry mean (58.527). P/E Ratio (0.877) is within average values for comparable stocks, (90.460). SBFM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.125) is also within normal values, averaging (19.547).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SBFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SBFM is expected to report earnings to fall 98.40% to -7 cents per share on May 08

Sunshine Biopharma Inc SBFM Stock Earnings Reports
Q1'24
Est.
$-0.08
Q4'23
Missed
by $4.97
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.06
The last earnings report on March 28 showed earnings per share of -500 cents, missing the estimate of -2 cents. With 35.59K shares outstanding, the current market capitalization sits at 6.02M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
6500 Trans-Canada Highway
Phone
+1 514 426-6161
Employees
83
Web
https://www.sunshinebiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IFBD2.120.02
+1.19%
Infobird Co Ltd
MTUS15.010.04
+0.27%
Metallus
TSE4.35N/A
N/A
Trinseo PLC
CWEN26.35-0.11
-0.42%
Clearway Energy
ACI19.64-0.56
-2.77%
Albertsons Companies

SBFM and Stocks

Correlation & Price change

A.I.dvisor tells us that SBFM and AKAN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and AKAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
+2.42%
AKAN - SBFM
23%
Poorly correlated
-5.39%
TXMD - SBFM
22%
Poorly correlated
+1.92%
EVOK - SBFM
22%
Poorly correlated
-1.35%
SUPN - SBFM
22%
Poorly correlated
-0.34%
SIGA - SBFM
21%
Poorly correlated
-0.24%
More